Literature DB >> 9212830

Analyzing cytotoxic T lymphocyte activity: a simple and reliable flow cytometry-based assay.

A E Mattis1, G Bernhardt, M Lipp, R Förster.   

Abstract

A flow cytometry-based assay for analyzing cytotoxic T lymphocyte (CTL) activity is presented. This new approach is characterized by easy handling, the generation of highly reproducible data sets and is not dependent on the use of radioactivity. Before exposure to primed CTL effector cells the target cells were labeled with the green fluorescent dye DiO18(3) which is incorporated stably into the cell membrane. After a 4-h incubation period, samples were counterstained with the red fluorescent nuclear dye propidium iodide in order to permit discrimination between live and dead cells within both cell populations. The assay has been used to quantitate CTL effector activity against allogeneic lymphoblasts. Results derived from this novel flow cytometry assay show an excellent correlation (r = 0.988) with data obtained using the standard 51chromium release assay. An additional advantage of the assay is that freshly prepared splenocytes may be used as target cells because culturing and activation of target cells is no longer required. The results demonstrate that the fluorescent dyes DiO18(3) and propidium iodide in combination with flow cytometry permit accurate analysis of cytotoxic T cell activity.

Entities:  

Mesh:

Year:  1997        PMID: 9212830     DOI: 10.1016/s0022-1759(97)00047-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.

Authors:  Liboria Siena; Elisabetta Pace; Maria Ferraro; Caterina Di Sano; Mario Melis; Mirella Profita; Mario Spatafora; Mark Gjomarkaj
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

2.  Dynein Separately Partners with NDE1 and Dynactin To Orchestrate T Cell Focused Secretion.

Authors:  Shubhankar Nath; Laura Christian; Sarah Youngsun Tan; Sanghee Ki; Lauren I R Ehrlich; Martin Poenie
Journal:  J Immunol       Date:  2016-08-17       Impact factor: 5.422

3.  B cells help alloreactive T cells differentiate into memory T cells.

Authors:  Y-H Ng; M H Oberbarnscheidt; H C K Chandramoorthy; R Hoffman; G Chalasani
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

4.  Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.

Authors:  R V Goddard; A G Prentice; J A Copplestone; E R Kaminski
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 5.  New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Authors:  Liubov Zaritskaya; Michael R Shurin; Thomas J Sayers; Anatoli M Malyguine
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

6.  High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.

Authors:  George V Aslanidi; Angela E Rivers; Luis Ortiz; Lakshmanan Govindasamy; Chen Ling; Giridhara R Jayandharan; Sergei Zolotukhin; Mavis Agbandje-McKenna; Arun Srivastava
Journal:  Vaccine       Date:  2012-04-10       Impact factor: 3.641

7.  Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer.

Authors:  Munjal Pandya; Kellee Britt; Brad Hoffman; Chen Ling; George V Aslanidi
Journal:  J Immunother       Date:  2015-09       Impact factor: 4.456

8.  Human CD8+ CD57- TEMRA cells: Too young to be called "old".

Authors:  Kriti Verma; Justyna Ogonek; Pavankumar Reddy Varanasi; Susanne Luther; Ivonne Bünting; Katrin Thomay; Yvonne Lisa Behrens; Eva Mischak-Weissinger; Lothar Hambach
Journal:  PLoS One       Date:  2017-05-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.